JOURNAL OF CLINICAL ONCOLOGY
4 yayın · 32 atıf
Yayınlar
| Başlık | Yıl | Yazar | Atıf |
|---|---|---|---|
|
The frequency of driver mutations in non-small cell lung cancer patients: The Turkish nation-wide, observational, Registurk-Lung study (updated analysis).
|
2025 | Turan, Nedim, Cil, Timucin, Artac, Mehmet +17 | 0 |
|
Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study
|
2024 | Janjigian, Yelena Y., Al-Batran, Salah-Eddin, Wainberg, Zev A. +17 | 31 |
|
Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results
|
2024 | Janjigian, Yelena Y., Kawazoe, Akihito, Xu, Jianming +12 | 1 |
|
The results of adding immunotherapy to chemotherapy in patients with small cell lung cancer: Registurk-Lung study-Real-world data
|
2024 | Cil, Timucin, Hacibekiroglu, Ilhan, Uncu, Dogan +17 | 0 |